3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
28
Carcinoma, Non-Small-Cell Lung
15
Squamous Cell Carcinoma of Head and Neck
14
Neoplasms
8
Colonic Neoplasms
7
Pancreatic Neoplasms
6
Neoplasm Metastasis
6
Lung Neoplasms
6
Rectal Neoplasms
5
Mouth Neoplasms
5
Head and Neck Neoplasms
5
Carcinoma, Squamous Cell
4
Carcinoma
4
Laryngeal Neoplasms
3
Hypopharyngeal Neoplasms
3
Thyroid Neoplasms
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Ovarian Neoplasms
2
Oropharyngeal Neoplasms
2
Endometrial Neoplasms
2
Breast Neoplasms
2
Urologic Neoplasms
1
Triple Negative Breast Neoplasms
1
Solid Tumors
1
Soft Tissue Neoplasms
1
Skin Neoplasms
1
Sarcoma
1
Recurrence
1
Pharyngeal Neoplasms
1
Neurofibromatosis 2
1
Interventions
Cisplatin
6
Paclitaxel
4
pembrolizumab
3
Fluorouracil
3
Carboplatin
3
tislelizumab
2
Taxes
2
Radiotherapy
2
Oxaliplatin
2
Leucovorin
2
Irinotecan
2
Injections
2
Capecitabine
2
130-nm albumin-bound paclitaxel
2
spartalizumab
1
lenvatinib
1
durvalumab
1
cixutumumab
1
apatinib
1
Tegafur
1
Surgical Procedures, Operative
1
Saline Solution
1
Radiation
1
Levoleucovorin
1
Laparoscopy
1
Histamine H2 Antagonists
1
Histamine Antagonists
1
Fulvestrant
1
Docetaxel
1
Dexamethasone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Esophageal Squamous Cell Carcinoma
×
Cetuximab
×
30 days
×
Clear all
No trials found.